Sorrento Therapeutics Inc

OTC: SRNEQ    
Share price (4/12/24): $0.03    
Market cap (4/12/24): $16.5 million
4 Sorrento Therapeutics Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.1
from 8-K 16 pages Manufacturing Technology Transfer Agreement
12/34/56
EX-10.1
from 8-K 7 pages Assignment, Assumption and Release Agreement
12/34/56
EX-10.1
from 8-K 24 pages Sorrento Therapeutics, Inc. 2019 Stock Incentive Plan Plan Document
12/34/56
EX-10.4
from 10-Q 14 pages Amounts and Terms of the Advances
12/34/56
EX-10.3
from 8-K 5 pages Amendment No.1 to Sponsor Support Agreement
12/34/56
EX-10.3
from 425 5 pages Amendment No.1 to Sponsor Support Agreement
12/34/56
EX-10.2
from 8-K 8 pages Stockholder Agreement
12/34/56
EX-10.2
from 425 8 pages Stockholder Agreement
12/34/56
EX-10.1
from 8-K 10 pages Contribution and Satisfaction of Indebtedness Agreement
12/34/56
EX-10.1
from 425 10 pages Contribution and Satisfaction of Indebtedness Agreement
12/34/56
EX-10.1
from 8-K 11 pages Consent Under and Amendment No. 4 to Indenture
12/34/56
EX-10.2
from 10-Q 2 pages Sorrento Therapeutics, Inc. Outside Director Compensation Policy Last Updated Effective January 1, 2022
12/34/56
EX-10.2
from 8-K 4 pages April 27, 2022 Elizabeth Czerepak […***…] […***…]
12/34/56
EX-10.1
from 8-K 4 pages April 27, 2022 Elizabeth Czerepak […***…] […***…]
12/34/56
EX-10.3
from 425 20 pages Amended and Restated Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 20 pages Amended and Restated Registration Rights Agreement
12/34/56
EX-10.2
from 425 9 pages Company Stockholder Support Agreement
12/34/56
EX-10.2
from 8-K 9 pages Company Stockholder Support Agreement
12/34/56
EX-10.1
from 425 11 pages Sponsor Support Agreement
12/34/56
EX-10.1
from 8-K 11 pages Sponsor Support Agreement
12/34/56